Table 18 (Abstract P247). Dynamics of growth rate and growth rate SDS, N = 125
From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part two
mean growth rate | baseline, sm/yr (SDS) | after 6 months sm/yr, (SDS) | after 12months, sm/yr, (SDS) | after 24months sm/yr, (SDS) | p (baseline/after 24 mounth) |
|---|---|---|---|---|---|
groups, N = 25 | |||||
group I | 3,16 ± 0,52 (-2,02 ± 0,70) | 3,98 ± 0,38 (-0,42 ± 0,54) | 6,30 ± 0,69 (2,97 ± 1,04) | 5,27 ± 0,65 (2,36 ± 0,92) | p = 0,011 p = 0,002 |
group II | 4,30 ± 0,30 (-2,30 ± 0,20) | 5,07 ± 0,36 (-0,29 ± 0,79) | 8,26 ± 0,98 (3,18 ± 1,18) | 6,67 ± 0,80 (2,40 ± 0,60) | p = 0,024 p = 0,009 |
group III | 3,28 ± 1,36 (-1,70 ± 1,38) | 6,50 ± 0,62 (0,63 ± 0,57) | 6,70 ± 0,71 (1,09 ± 0,79) | 5,38 ± 0,56 (0,11 ± 0,40) | p = 0,036 p = 0,015 |
group IV | 4,90 ± 0,77 (0,02 ± 0,62) | 7,40 ± 0,79 (1,80 ± 0,88) | 6,90 ± 0,78 (2,17 ± 1,06) | 6,44 ± 0,58 (1,40 ± 0,70) | p = 0,058 p = 0,051 |
group V | 5,21 ± 1,01 (-0,25 ± 1,41) | 7,21 ± 0,76 (2,21 ± 0,96) | 5,64 ± 0,43 (0,35 ± 0,70) | 5,14 ± 0,57 (0,26 ± 0,53) | p = 0,083 p = 0,088 |